Showing results (221-230 of 329) with videos related to

Sort By:
Pageof 33
The Journal of Infectious Diseases|April 20, 2026
Evaluation of serum antibodies as correlates of protection against norovirus infection and diseaseSavannah L Miller, W Zane Billings, Murphy John, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2005
Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccineDavid I Bernstein, Fred Y Aoki, Stephen K Tyring, et al.
The Journal of Allergy and Clinical Immunology|April 16, 2010
Breast-feeding, aeroallergen sensitization, and environmental exposures during infancy are determinants of childhood allergic rhinitisChristopher D Codispoti, Linda Levin, Grace K LeMasters, et al.
The New England Journal of Medicine|November 22, 2002
Glycoprotein-D-adjuvant vaccine to prevent genital herpesLawrence R Stanberry, Spotswood L Spruance, Anthony L Cunningham, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 17, 2006
Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT)Joel I Ward, James D Cherry, Swei-Ju Chang, et al.
The Journal of Pediatrics|May 23, 2018
Racial and Ethnic Differences in the Prevalence of Congenital Cytomegalovirus InfectionKaren B Fowler, Shannon A Ross, Masako Shimamura, et al.
The New England Journal of Medicine|October 14, 2005
Efficacy of an acellular pertussis vaccine among adolescents and adultsJoel I Ward, James D Cherry, Swei-Ju Chang, et al.
The Journal of Pediatrics|October 28, 2008
Associations between multiple environmental exposures and Glutathione S-Transferase P1 on persistent wheezing in a birth cohortKathy T Schroer, Jocelyn M Biagini Myers, Patrick H Ryan, et al.
The Journal of Infectious Diseases|March 23, 2017
Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection: Findings From a Randomized TrialDavid I Bernstein, Anna Wald, Terri Warren, et al.
Vaccine|October 28, 2009
Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteersDavid I Bernstein, Elizabeth A Reap, Kevin Katen, et al.
Pageof 33